Phage-bacterial evolutionary interactions: experimental models and complications

References

• Abdelsattar AS, Dawooud A, Rezk N, Makky S, Safwat A, Richards PJ, El-Shibiny A. 2021. How to train your phage: the recent efforts in phage training. Biologics. 1(2):70–88.
   Google Scholar
• Agrawal A, Lively CM. 2002. Infection genetics: gene-for-gene versus matching-alleles models and all points in between. Evol Ecol Res. 4:79–90.
   Web of Science ®Google Scholar
• Alam S, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, et al. 2016. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine. 4:124–137.
   PubMed Web of Science ®Google Scholar
• Attridge SR, Fazeli A, Manning PA, Stroeher UH. 2001. Isolation and characterization of bacteriophage-resistant mutants of Vibrio cholerae O139. Microb Pathog. 30(4):237–246.
   PubMed Web of Science ®Google Scholar
• Avrani S, Wurtzel O, Sharon I, Sorek R, Lindell D. 2011. Genomic Island variability facilitates prochlorococcus-virus coexistence. Nature. 474(7353):604–608.
   PubMed Web of Science ®Google Scholar
• Bohannan BJM, Kerr B, Jessup CM, Hughes JB, Sandvik G. 2002. Trade-offs and coexistence in microbial microcosms. Antonie Van Leeuwenhoek. 81(1–4):107–115.
   PubMed Web of Science ®Google Scholar
• Bohannan BJM, Travisano M, Lenski RE. 1999. Epistatic interactions can lower the cost of resistance to multiple consumers. Evolution. 53(1):229–292.
   Web of Science ®Google Scholar
• Borges AL. 2021. How to train your bacteriophage. Proc Natl Acad Sci USA. 118(28):e2109434118.
   PubMed Web of Science ®Google Scholar
• Borin JM, Avrani S, Barrick JE, Petrie KL, Meyer JR. 2021. Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of page resistance. Proc Natl Acad Sci USA. 118(23):e2104592118.
   PubMed Web of Science ®Google Scholar
• Brockhurst MA, Buckling A, Poullain V, Hochberg ME. 2007. The impact of migration from parasite-free patches on antagonistic host-parasite coevolution. Evolution. 61(5):1238–1243.
   PubMed Web of Science ®Google Scholar
• Brockhurst MA, Koskella B, Zhang QG. 2017. Bacteriophages. In: Harper D, AbedonS, BurrowesB, McConville M, editors. Bacteria-Phage antagonistic coevolution and the implications for phage therapy. Cham: Springer; p. 1–12.
   Google Scholar
• Brussow H, Canchaya C, Hardt WD. 2004. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev. 68(3):560–602.
   PubMed Web of Science ®Google Scholar
• Burmeister AR, Fortier A, Roush C, Lessing AJ, Bender RG, Barahman R, Grant R, Chan BK, Turner PE. 2020. Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance. Proc Natl Acad Sci USA. 117(21):11207–11216.
   PubMed Web of Science ®Google Scholar
• Capparelli R, Nocerino N, Lanzetta R, Silipo A, Amoresano A, Giangrande C, Becker K, Blaiotta G, Evidente A, Cimmino A, et al. 2010. Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against Staphylococcal infection in mice. PLOS One. 5(7):e11720.
   PubMed Web of Science ®Google Scholar
• Castillo D, Christiansen RH, Dalsgaard I, Madsen L, Middelboe M. 2015. Bacteriophage resistance mechanisms in the fish pathogen Flavobacterium psychrophilum: linking genomic mutations to changes in bacterial virulence factors. Appl Environ Microbiol. 81(3):1157–1167.
   PubMed Web of Science ®Google Scholar
• Castillo D, Higuera G, Villa M, Middelboe M, Dalsgaard I, Madsen L, Espejo RT. 2012. Diversity of Flavobacterium psychrophilum and the potential use of its phages for protection against bacterial cold water disease in salmonids. J Fish Dis. 35(3):193–201.
   PubMed Web of Science ®Google Scholar
• Chabas H, van Houte S, Høyland-Kroghsbo NM, Buckling A, Westra ER. 2016. Immigration of susceptible hosts triggers the evolution of alternative parasite defense strategies. Proc R Soc B. 283(1837):20160721.
   PubMed Web of Science ®Google Scholar
• Chan BK, Abedon ST. 2012. Phage therapy pharmacology phage cocktails. Adv Appl Microbiol. 78:1–23.
   PubMed Web of Science ®Google Scholar
• Chan BK, Abedon ST, Loc-Carrillo C. 2013. Phage cocktails and the future of phage therapy. Future Microbiol. 8(6):769–783.
   PubMed Web of Science ®Google Scholar
• Chan BK, Turner PE, Kim S, Mojibian HR, Elefteriades JA, Narayan D. 2018. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol Med Public Health. 2018(1):60–66.
   PubMed Web of Science ®Google Scholar
• Dadgostar P. 2019. Antimicrobial resistance: implications and costs. Infect Drug Resist. 12:3903–3910.
   PubMed Web of Science ®Google Scholar
• de Kraker MEA, Stewardson AJ, Harbarth S. 2016. Will 10 million people die a year due to antimicrobial resistance by 2050?. PLOS Med. 13(11):e1002184.
   PubMed Web of Science ®Google Scholar
• de Sousa MJ, Balbontín R, Durão P, Gordo I. 2017. Multidrug-resistant bacteria compensate for the epistasis between resistances. PLoS Biol. 15(4):e2001741.
   PubMed Web of Science ®Google Scholar
• Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K, Gilmour KC, Soothill J, Jacobs-Sera D, Schooley RT, et al. 2019. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 25(5):730–733.
   PubMed Web of Science ®Google Scholar
• Denes T, den Bakker HC, Tokman JI, Guldimann C, Wiedmann M. 2015. Selection and characterization of phage-resistant mutant strains of Listeria monocytogenes reveal host genes linked to phage adsorption. Appl Environ Microbiol. 81(13):4295–4305.
   PubMed Web of Science ®Google Scholar
• Dennehy JJ. 2012. What can phages tell us about host-pathogen coevolution?. Int J Evol Biol. 2012. Article ID: 396165.
   PubMedGoogle Scholar
• Filippov AA, Sergueev KV, He Y, Huang X-Z, Gnade BT, Mueller AJ, Fernandez-Prada CM, Nikolich MP. 2011. Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice. PLOS One. 6(9):e25486.
   PubMed Web of Science ®Google Scholar
• Gandon S, Buckling A, Decaestecker E, Day T. 2008. Host-parasite coevolution and patterns of adaptation across time and space. J Evol Biol. 21(6):1861–1866.
   PubMed Web of Science ®Google Scholar
• Głowacka-Rutkowska A, Gozdek A, Empel J, Gawor J, Żuchniewicz K, Kozińska A, Dębski J, Gromadka R, Łobocka M. 2019. The ability of lytic Staphylococcal podovirus vB_SauP_phiAGO1.3 to coexist in equilibrium with its host facilitates the selection of host mutants of attenuated virulence but does not preclude the phage antistaphylococcal activity in a nematode infection model. Front Microbiol. 9(9):3227.
   PubMedGoogle Scholar
• Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, et al. 2012. A method for generation phage cocktail with great therapeutic potential. PLOS One. 7(3):e31698.
   PubMed Web of Science ®Google Scholar
• Gurney J, Pradier L, Griffin JS, Gougat-Barbera C, Chan BK, Turner PE, Kaltz O, Hochberg ME. 2020. Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Pseudomonas aeruginosa. Evol Med Public Health. 2020(1):148–157.
   PubMedGoogle Scholar
• Habusha M, Tzipilevich E, Fiyaksel O, Ben-Yehuda S. 2019. A mutant bacteriophage evolved to infect resistant bacteria gained a broader host range. Mol Microbiol. 111(6):1463–1475.
   PubMed Web of Science ®Google Scholar
• Hall AR, Scanlan PD, Morgan AD, Buckling A. 2011. Host-parasite coevolutionary arms races give way to fluctuating selection. Ecol Lett. 14(7):635–642.
   PubMed Web of Science ®Google Scholar
• Heierson A, Sidén I, Kivaisi A, Boman HG. 1986. Bacteriophage-resistant mutants of Bacillus thuringiensis with decreased virulence in pupae of Hyalophora cecropia. J Bacteriol. 167(1):18–24.
   PubMed Web of Science ®Google Scholar
• Holguín AV, Cárdenas P, Prada-Peñaranda C, Rabelo LL, Buitrago C, Clavijo V, Oliveira G, Leekitcharoenphon P, Møller AF, Vives MJ. 2019. Host resistance, genomics and population dynamics in a Salmonella enteritidis and phage system. Viruses. 11(2):188.
   PubMed Web of Science ®Google Scholar
• Jault P, Leclerc T, Jennes S, Pirnay J-P, Que Y-A, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, et al. 2019. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (phagoburn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. 19(1):35–45.
   PubMed Web of Science ®Google Scholar
• Jessup CM, Bohannan BJM. 2008. The shape of an ecological trade-off varies with environment. Ecol Lett. 11(9):947–959.
   PubMed Web of Science ®Google Scholar
• Kawecki D, Pacholczyk M, Lagiewska B, Sawicka-Grzelak A, Durlik M, Mlynarczyk G, Chmura A. 2014. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility. Transplant Proc. 46(8):2777–2781.
   PubMed Web of Science ®Google Scholar
• Koskella B, Brockhurst MA. 2014. Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol Rev. 38(5):916–931.
   PubMed Web of Science ®Google Scholar
• Koskella B, Taylor T, Bates J, Buckling A. 2011. Using experimental evolution to explore natural patterns between bacterial motility and resistance to bacteriophages. ISME J. 5(11):1809–1817.
   PubMed Web of Science ®Google Scholar
• Laanto E, Mäkelä K, Hoikkala V, Ravantti JJ, Sundberg L-R. 2020. Adapting a phage to combat phage resistance. Antibiotics. 9(6):291.
   Google Scholar
• Labrie S, Samson J, Moineau S. 2010. Bacteriophage resistance mechanisms. Nat Rev Microbiol. 8(5):317–327.
   PubMed Web of Science ®Google Scholar
• Le S, Yao X, Lu S, Tan Y, Rao X, Li M, Jin X, Wang J, Zhao Y, Wu NC, et al. 2014. Chromosomal DNA deletion confers phage resistance to Pseudomonas aeruginosa. Sci Rep. 4:4738.
   PubMed Web of Science ®Google Scholar
• Leitner L, Ujmajuridze A, Chanishvili N, Goderdzishvili M, Chkonia I, Rigvava S, Chkhotua A, Changashvili G, McCallin S, Schneider MP, et al. 2021. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. Lancet Infect Dis. 21(3):427–436.
   PubMed Web of Science ®Google Scholar
• Lennon J, Khatana S, Marston M, Martiny J. 2007. Is there a cost of virus resistance in marine cyanobacteria?. Isme J. 1(4):300–312.
   PubMed Web of Science ®Google Scholar
• Lenski RE. 1988. Experimental studies of pleiotropy and epistasis in Escherichia coli. I. Variation in competitive fitness among mutants resistant to virus T4. Evolution. 42(3):425–432.
   PubMed Web of Science ®Google Scholar
• Li G, Leung CY, Wardi Y, Debarbieux L, Weitz JS. 2020. Optimizing the timing and composition of therapeutic phage cocktails: a control-theoretic approach. Bull Math Biol. 82(6):75.
   PubMed Web of Science ®Google Scholar
• Lion S, Gandon S. 2015. Evolution of spatially structured host-parasite interactions. J Evol Biol. 28(1):10–28.
   PubMed Web of Science ®Google Scholar
• Loc-Carrillo C, Abedon ST. 2011. Pros and cons of phage therapy. Bacteriophage. 1(2):111–114.
   PubMedGoogle Scholar
• Loftus M, Hassouneh SAD, Yooseph S. 2021. Bacterial associations in the healthy human gut microbiome across populations. Sci Rep. 11(1):2828.
   PubMed Web of Science ®Google Scholar
• Lythgoe KA, Chao L. 2003. Mechanisms of coexistence of a bacteria and a bacteriophage in a spatially homogeneous environment. Ecol Letters. 6(4):326–334.
   Web of Science ®Google Scholar
• Mangalea MR, Duerkop BA. 2020. Fitness trade-offs resulting from bacteriophage resistance potentiate synergistic antibacterial strategies. Infect Immun. 88(7):e00926–19.
   PubMed Web of Science ®Google Scholar
• Meyer JR, Agrawal AA, Quick RT, Dobias DT, Schneider D, Lenski RE. 2010. Parallel changes in host resistance to viral infection during 45 000 generations of relaxed selection. Evolution. 64(10):3024–3034.
   PubMed Web of Science ®Google Scholar
• Middelboe M, Holmfeldt K, Riemann L, Nybroe O, Haaber J. 2009. Bacteriophages drive strain diversification in a marine Flavobacterium: implications for phage resistance and physiological properties. Environ Microbiol. 11(8):1971–1982.
   PubMed Web of Science ®Google Scholar
• Mizoguchi K, Morita M, Fischer CR, Yoichi M, Tanji Y, Unno H. 2003. Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl Environ Microbiol. 69(1):170–176.
   PubMed Web of Science ®Google Scholar
• Morgan AD, Buckling A. 2006. Relative number of generations of hosts and parasites does not influence parasite local adaptation in coevolving populations of bacteria and phages. J Evol Biol. 19(6):1956–1963.
   PubMed Web of Science ®Google Scholar
• Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, Knight GM, Robotham JV. 2018. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 7:58.
   PubMed Web of Science ®Google Scholar
• Naylor NR, Pouwels KB, Hope R, Green N, Henderson KL, Knight GM, Atun R, Robotham JV, Deeny SR. 2019. The health and cost burden of antibiotic resistant and susceptible Escherichia coli Bacteraemia in the English hospital setting: a national retrospective cohort study. PLOS One. 14(9):e0221944.
   PubMed Web of Science ®Google Scholar
• Nesher L, Rolston KV. 2014. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection. 42(1):5–13.
   PubMed Web of Science ®Google Scholar
• Nikolich MP, Filippov AA. 2020. Bacteriophage therapy: developments and directions. Antibiotics. 9(3):135.
   Google Scholar
• Oechslin F. 2018. Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses. 10(7):351.
   PubMed Web of Science ®Google Scholar
• Oliver A, Cantón R, Campo P, Baquero F, Blázquez J. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science. 288(5469):1251–1253.
   PubMed Web of Science ®Google Scholar
• Oyejobi GK, Xiong D, Shi M, Zhang X, Yang H, Xue H, Ogolla F, Wei H. 2022. Genetic signatures from adaptation of bacteria to lytic phage identify potential agents to aid phage killing of multidrug resistant Acinetobacter baumannii. J Bacteriol. 204(3):e00593–21.
   PubMed Web of Science ®Google Scholar
• Pedro G, Ben A, Angus, B. 2015. Population mixing promotes arms race host–parasite coevolution. Proc R Soc B: Biol Sci. 282(1798):20142297.
   PubMed Web of Science ®Google Scholar
• Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A. 2009. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care. 18(6):237–238.
   PubMedGoogle Scholar
• Roach DR, Leung CY, Henry M, Morello E, Singh D, Di Santo JP, Weitz JS, Debarbieux L. 2017. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe. 22(1):38–47.
   PubMed Web of Science ®Google Scholar
• Rohwer SL, Benler F, Segall AM. 2017. Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails to Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection. Antimicrob. Agents Chemother. 61(10):e00954-17–e00954-17. https://doi.org/10.1128/AAC.00954-17.
   PubMed Web of Science ®Google Scholar
• Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, et al. 2017. Development and use of personalized acteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. 61(10):e00954–17.
   PubMed Web of Science ®Google Scholar
• Salazar KC, Ma L, Green SI, Zulk JJ, Trautner BW, Ramig RF, Clark JR, Terwilliger AL, Maresso AW. 2021. Antiviral resistance and phage counter adaptation to antibiotic-resistant extraintestinal pathogenic Escherichia coli. MBio. 12(2):e00211–e00221.
   PubMedGoogle Scholar
• Schooley RT, Strathdee S. 2020. Treat phage like living antibiotics. Nat Microbiol. 5(3):391–392.
   PubMed Web of Science ®Google Scholar
• Schroven K, Aertsen A, Lavigne R. 2021. Bacteriophages as drivers of bacterial virulence and their potential for biotechnological exploitation. FEMS Microbiol Rev. 45(1):fuaa041.
   PubMed Web of Science ®Google Scholar
• Seed KD, Faruque SM, Mekalanos JJ, Calderwood SB, Qadri F, Camilli A. 2012. Phase variable O antigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in Vibrio cholerae O1. PLOS Pathog. 8(9):e1002917.
   PubMed Web of Science ®Google Scholar
• Sefton AM. 2002. Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium. Drugs. 62(4):557–566.
   PubMed Web of Science ®Google Scholar
• Shen Y, Loessner MJ. 2021. Beyond antibacterials-exploring bacteriophages as antivirulence agents. Curr Opin Biotechnol. 68:166–173.
   PubMed Web of Science ®Google Scholar
• Silva JB, Storms Z, Sauvageau D. 2016. Host receptors for bacteriophage adsorption. FEMS Microbiol Lett. 363(4):fnw002.
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, et al. 2010. Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network. Pediatrics. 126(3):443–456.
   PubMed Web of Science ®Google Scholar
• Thursby E, Juge N. 2017. Introduction to the human gut microbiota. Biochem J. 474(11):1823–1836.
   PubMed Web of Science ®Google Scholar
• Torres-Barceló C. 2018. Phage therapy faces evolutionary challenges. Viruses. 10(6):323.
   PubMed Web of Science ®Google Scholar
• Wagner PL, Waldor MK. 2002. Bacteriophage control of bacterial virulence. Infect Immun. 70(8):3985–3993.
   PubMed Web of Science ®Google Scholar
• Wandro S, Ghatbale P, Attai H, Hendrickson C, Samillano C, Suh J, Pride DT, Whiteson K. 2021. Phage cocktails can prevent the evolution of phage-resistant Enterococcus. BioRxiv. 428553.
   Google Scholar
• Wright RCT, Friman V-P, Smith MCM, Brockhurst MA. 2018. Cross-resistance is modular in bacteria-phage interactions. PLOS Biol. 16(10):e2006057.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shen W, Zhong Q, Chen Q, He X, Baker JL, Xiong K, Jin X, Wang J, Hu F, et al. 2020. Development of a bacteriophage cocktail to constrain the emergence of phage-resistant Pseudomonas aeruginosa. Front Microbiol. 11:327.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Peng Q, Zhang S, Liu T, Yang S, Yu Q, Wu Y, Gao M. 2019. Phage reduce stability for regaining infectivity during antagonistic coevolution with host bacterium. Viruses. 11(2):118.
   PubMed Web of Science ®Google Scholar
• Zhang Q-G, Chu X-L, Buckling A. 2021. Overcoming the growth-infectivity trade-off in a bacteriophage slows bacterial resistance evolution. Evol Appl. 14(8):2055–2059.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xiong D, Yu J, Yang H, He P, Wei H. 2021. Genetic polymorphism drives susceptibility between bacteria and bacteriophages. Front Microbiol. 12:627897.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Bao H, Zhang H, Pang M, Zhu S, Wang R. 2021. A spontaneous rapZ mutant impairs infectivity of lytic bacteriophage vB_EcoM_JS09 against enterotoxigenic Escherichia coli. MSphere. 6(2):e01286–20.
   PubMed Web of Science ®Google Scholar